Literature DB >> 29099511

PURLs: The benefits--and limits--of PPIs with warfarin regimens.

Alicia Ludden-Schlatter1, James J Stevermer1.   

Abstract

Patients on warfarin plus antiplatelet/NSAID regimens are likely to benefit from the gastroprotective effect of PPIs. For patients taking warfarin alone, it's a different story.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29099511      PMCID： PMC5687279     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  13 in total

1.  ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Authors:  Deepak L Bhatt; James Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley; Robert A Harrington; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Mark A Hlatky; Sanjay Kaul; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Richard S Schofield; Robert S Rosenson; James H Stein; Howard H Weitz; Deborah J Wesley
Journal:  J Am Coll Cardiol       Date:  2008-10-28       Impact factor: 24.094

2.  Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Walter E Smalley; James R Daugherty; William D Dupont; C Michael Stein
Journal:  Gastroenterology       Date:  2016-09-14       Impact factor: 22.682

3.  Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.

Authors:  Kueiyu Joshua Lin; Sonia Hernández-Díaz; Luis A García Rodríguez
Journal:  Gastroenterology       Date:  2011-03-31       Impact factor: 22.682

4.  Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.

Authors:  Angel Lanas; Luis A García-Rodríguez; Maria T Arroyo; Luis Bujanda; Fernando Gomollón; Montserrat Forné; Sofía Aleman; David Nicolas; Faust Feu; Antonio González-Pérez; Ana Borda; Manuel Castro; Maria Jose Poveda; Juan Arenas
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

Review 5.  Reducing adverse effects of proton pump inhibitors.

Authors:  Paul W Ament; Daniel B Dicola; Mary E James
Journal:  Am Fam Physician       Date:  2012-07-01       Impact factor: 3.292

6.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Ansell; Jack Hirsh; Elaine Hylek; Alan Jacobson; Mark Crowther; Gualtiero Palareti
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

7.  Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.

Authors:  Willy Gomm; Klaus von Holt; Friederike Thomé; Karl Broich; Wolfgang Maier; Anne Fink; Gabriele Doblhammer; Britta Haenisch
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 8.  Pharmacology of proton pump inhibitors.

Authors:  Jai Moo Shin; George Sachs
Journal:  Curr Gastroenterol Rep       Date:  2008-12

Review 9.  Effectiveness and costs of implementation strategies to reduce acid suppressive drug prescriptions: a systematic review.

Authors:  Hugo M Smeets; Arno W Hoes; Niek J de Wit
Journal:  BMC Health Serv Res       Date:  2007-11-05       Impact factor: 2.655

10.  Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials.

Authors:  Maribel Salas; Alexandra Ward; Jaime Caro
Journal:  BMC Gastroenterol       Date:  2002-07-15       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.